
Athenex ATNX
Annual report 2022
added 03-20-2023
Athenex Operating Cycle 2011-2026 | ATNX
Annual Operating Cycle Athenex
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 247 | 239 | 170 | 231 | 277 | 322 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 322 | 170 | 248 |
Quarterly Operating Cycle Athenex
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 114 | - | 220 | - | 193 | 218 | 202 | 243 | 168 | 133 | 182 | 234 | 253 | 244 | 194 | 240 | 284 | 380 | 202 | 168 | 200 | 464 | 446 | 49.6 | 45.1 | 24.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 464 | 24.4 | 213 |
Operating Cycle of other stocks in the Drug manufacturers industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alimera Sciences
ALIM
|
181 | - | - | $ 142 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
121 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
576 | - | - | $ 754 M | ||
|
Canopy Growth Corporation
CGC
|
230 | $ 1.17 | -1.3 % | $ 126 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
16.5 | - | 7.5 % | $ 6.35 M | ||
|
Cronos Group
CRON
|
425 | $ 2.68 | -0.93 % | $ 1.41 B | ||
|
Agile Therapeutics
AGRX
|
146 | - | 10.11 % | $ 58.2 M | ||
|
Catalent
CTLT
|
152 | - | - | $ 11.5 B | ||
|
DURECT Corporation
DRRX
|
560 | - | - | $ 50.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
214 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
180 | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | ||
|
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | ||
|
Emergent BioSolutions
EBS
|
237 | $ 12.87 | 3.04 % | $ 659 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
416 | $ 21.5 | -0.12 % | $ 2.05 B | ||
|
Evolus
EOLS
|
104 | $ 6.16 | -8.33 % | $ 382 M | ||
|
Harrow Health
HROW
|
102 | $ 52.73 | 5.65 % | $ 1.72 B | ||
|
Jupiter Wellness
JUPW
|
194 | - | - | $ 33.6 M | ||
|
China Pharma Holdings
CPHI
|
198 | $ 1.22 | 0.83 % | $ 21.3 M | ||
|
OrganiGram Holdings
OGI
|
2.92 K | $ 1.7 | -2.02 % | $ 402 M | ||
|
Bausch Health Companies
BHC
|
78.9 | $ 7.43 | 3.05 % | $ 2.71 B | ||
|
Lannett Company
LCI
|
210 | - | 1.15 % | $ 7.11 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
614 | $ 4.02 | 1.01 % | $ 56.5 M | ||
|
Organogenesis Holdings
ORGO
|
159 | $ 4.34 | -6.36 % | $ 571 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
182 | $ 3.83 | 5.27 % | $ 4.75 M | ||
|
Pacira BioSciences
PCRX
|
246 | $ 25.49 | 4.19 % | $ 1.18 B | ||
|
Aurora Cannabis
ACB
|
1.45 K | $ 4.25 | -2.19 % | $ 86.3 M | ||
|
Rockwell Medical
RMTI
|
65.9 | $ 0.97 | 12.89 % | $ 22.6 M | ||
|
PetIQ
PETQ
|
108 | - | 1.64 % | $ 400 M | ||
|
Perrigo Company plc
PRGO
|
201 | $ 14.41 | 3.74 % | $ 1.98 B | ||
|
ProPhase Labs
PRPH
|
141 | - | - | $ 5.07 M | ||
|
Veru
VERU
|
271 | $ 2.29 | 0.66 % | $ 309 M | ||
|
Radius Health
RDUS
|
220 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
112 | - | -4.76 % | $ 65.3 M | ||
|
cbdMD
YCBD
|
176 | $ 1.01 | -12.93 % | $ 4.36 M | ||
|
OptiNose
OPTN
|
508 | - | - | $ 1.08 B | ||
|
Assertio Holdings
ASRT
|
459 | $ 9.32 | 1.97 % | $ 662 M | ||
|
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | ||
|
SCYNEXIS
SCYX
|
106 | $ 0.64 | -0.45 % | $ 30.6 M | ||
|
Tilray
TLRY
|
222 | $ 9.4 | -3.34 % | $ 5.81 B | ||
|
TherapeuticsMD
TXMD
|
3.34 K | $ 1.79 | 8.18 % | $ 18.7 M | ||
|
Zomedica Corp.
ZOM
|
196 | - | -0.21 % | $ 98 M |